Röhrig Gabriele, Polidori Maria Cristina, Rascher Katherine, Schaller Mathias, Benzing Thomas, von Gersdorff Gero
Department II of Internal Medicine, Ageing Clinical Research, University Hospital of Cologne, Cologne, Germany.
Department of Geriatrics, St. Marien Hospital, Cologne, Germany.
Z Gerontol Geriatr. 2018 Jan;51(1):60-66. doi: 10.1007/s00391-016-1149-3. Epub 2016 Nov 10.
Patients with end-stage renal disease (ESRD) requiring hemodialysis are typically characterized by multimorbidity and increasingly by advanced age; however, there are few data on their geriatric needs.
The aim of the study was to evaluate the clinical characteristics of a large cohort of incident patients in ambulatory hemodialysis units with a particular focus on those aged over 80 years in Germany.
The electronic patient registry of the Board of Trustees (Kuratorium) for Dialysis and Kidney Transplantation (KfH) was searched for all patients who began hemodialysis in 1 of the 191 units between 2007 and 2013 and were 65 years and older. Patients were analyzed by age (65-79 years and ≥80 years) for clinical and biochemical characteristics, mortality, quality of life and hospitalizations.
Of the 21,355 incident patients, a total of 13,872 (65%) were over 65 years old, with 9998 (46.8%) aged between 65 and 79 years and 3874 (18.1%) patients 80 years or older (oldest old). The spectrum of morbidity was comparable between the two age groups but there was a significantly higher prevalence of anemia, hypoalbuminemia and multimorbidity (>four comorbidities) in the older age group. Median survival was 4.5 years (1638 days) in the younger age group and 2.7 years (978 days) in the older group. Almost half of the patients experienced at least one episode of hospitalization during the first year but there were no significant differences between the age groups (45.9% in younger vs. 47% in older patients). In the older age group 463 (12%) patients survived more than 5 years after initiation of hemodialysis despite the presence of multiple risk factors for adverse clinical outcome.
More than half of the chronic ambulatory hemodialysis patients were of advanced age and had a very high burden of multimorbidity. Nevertheless, a subgroup of ERSD patients over 80 years old survived at least 5 years on hemodialysis despite the presence of multiple risk factors for adverse clinical outcome. Identification of these patients as well as optimized care for frail hemodialysis patients will require application of geriatric assessment tools in addition to traditional parameters in nephrology. The development and validation of such tools should be the subject of further clinical studies.
需要进行血液透析的终末期肾病(ESRD)患者通常具有多种合并症,且年龄越来越大;然而,关于他们的老年护理需求的数据却很少。
本研究的目的是评估德国门诊血液透析单位一大群初诊患者的临床特征,特别关注80岁以上的患者。
在透析和肾移植董事会(KfH)的电子患者登记系统中搜索2007年至2013年间在191个单位中的1个开始进行血液透析且年龄在65岁及以上的所有患者。按年龄(65 - 79岁和≥80岁)对患者的临床和生化特征、死亡率、生活质量和住院情况进行分析。
在21355例初诊患者中,共有13872例(65%)年龄超过65岁,其中9998例(46.8%)年龄在65至79岁之间,3874例(18.1%)患者年龄在80岁及以上(高龄老人)。两个年龄组的发病谱相当,但老年组贫血、低白蛋白血症和多种合并症(>4种合并症)的患病率明显更高。较年轻年龄组的中位生存期为4.5年(1638天),较老年组为2.7年(978天)。几乎一半的患者在第一年至少经历过一次住院,但年龄组之间无显著差异(较年轻患者为45.9%,较老年患者为47%)。在老年组中,463例(占12%)患者在开始血液透析后尽管存在多种不良临床结局的危险因素,但仍存活超过5年。
超过一半的慢性门诊血液透析患者年龄较大,且合并症负担非常高。然而,尽管存在多种不良临床结局的危险因素,但80岁以上的ESRD患者亚组在血液透析治疗下至少存活了5年。识别这些患者以及为体弱的血液透析患者提供优化护理,除了肾脏病学中的传统参数外,还需要应用老年评估工具。此类工具的开发和验证应成为进一步临床研究的主题。